Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Little is known about the neuropsychological effects of risperidone in children with pervasive developmental disorders. METHOD: Twenty-four children (aged 5-17 years) with pervasive developmental disorders and co-morbid disruptive behavior who responded favorably to open-label treatment with risperidone as part of a previously described controlled discontinuation study completed two different computerized attention tasks at baseline, weeks 4, 8, and 24 of open-label treatment, and, at 8 weeks after random assignment to either placebo or risperidone. The primary efficacy measures were response latencies to visually presented stimuli requiring two different types of attention-controlled processing, i.e., focused and divided attention. RESULTS: About half of the clinical responders did not produce valid performance measures. These could be shown to be of younger mental age and less adaptive as measured by the Vineland Behavior Scales. For the valid task performers divided attention (serial search in working memory) was shown to regress in the placebo group (n = 7), while in the risperidone group (n = 7) there was further improvement. No such group difference was found for focused attention. CONCLUSIONS: The study suggests a beneficial effect of risperidone after several months of treatment, enhancing divided attention in children with pervasive developmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Brief Report: Specific Executive Function Profiles in Three Neurodevelopmental Disorders
Ozonoff, S., & Jensen, J. (1999) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1023052913110 · Cited by 724 · cited 2×
“This suggests that the use of risperidone does not interfere with learning to neglect irrelevant information when such a task is re-peatedly similar task paradigms (Althaus et al. 1996; Ozonoff and Jensen 1999).”
Intact and Impaired Memory Functions in Autism
Bennetto, L., Pennington, B. F., & Rogers, S. J. (1996) · Child Development · doi:10.2307/1131734 · Cited by 550
Haznedar, M. M., Buchsbaum, M. S., Wei, T.-C., Hof, P. R., Cartwright, C., Bienstock, C. A., & Hollander, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1994 · Cited by 420 · cited 1×
“The anterior cingulate gyrus has a high serotonin receptor density (Haznedar et al. 1997), and an imbalance in serotonin neuro-transmission has been associated with cognitive and behavioral manifestations of autism (Piven et al. 1991).”
Language, social, and executive functions in high functioning Autism: a continuum of performance
Landa, R. J., & Goldberg, M. C. (2005) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-005-0001-1 · Cited by 296 · cited 11×
“This study was the first to have evaluated neuropsychological effects of risperidone in children and adolescents with PDDs.”
InfluentialFindling, R. L., Aman, M. G., Eerdekens, M., Derivan, A., Lyons, B., & The Risperidone Disruptive Behavior Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.677 · Cited by 161 · cited 2×
“…Risperidone Disruptive Behavior Study Group, the degree of sedation was mild and not associated with cognitive deterioration (Turgay et al. 2002; Findling et al. 2004 In fact, there were similar improvements in tests for verbal learning, attention, and memory as reported for adult patients with…”
Althaus, M., Mulder, L. J. M., Mulder, G., Aarnoudse, C. C., & Minderaa, R. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00374-6 · Cited by 63
Self-citation
Cited by
Harfterkamp, M., van de Loo-Neus, G., Minderaa, R. B., van der Gaag, R.-J., Escobar, R., Schacht, A., Pamulapati, S., Buitelaar, J. K., & Hoekstra, P. J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.04.011 · Cited by 171
Self-citationRodrigues, R., Lai, M., Beswick, A., Gorman, D. A., Anagnostou, E., Szatmari, P., Anderson, K. K., & Ameis, S. H. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13305 · Cited by 98
Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders
Aman, M. G., Farmer, C. A., Hollway, J., & Arnold, L. E. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.06.009 · Cited by 82
Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior
Aman, M. G., Hollway, J. A., McDougle, C. J., Scahill, L., Tierney, E., McCracken, J. T., Arnold, L. E., Vitiello, B., Ritz, L., Gavaletz, A., et al. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0133 · Cited by 80
“However, when they did occur, changes favored risperidone in the Troost et al. (2006) study (working memory) and in the Aman et al. (2007) study (response time, seat activity, static tremor).”
InfluentialNijmeijer, J. S., Hartman, C. A., Rommelse, N. N. J., Altink, M. E., Buschgens, C. J. M., Fliers, E. A., Franke, B., Minderaa, R. B., Ormel, J., Sergeant, J. A., et al. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02277.x · Cited by 57
“, 2002) and executive functioning (Troost et al., 2006).”
BackgroundSelf-citation
Metadata
- Authors
- Troost, P. W., Althaus, M., Lahuis, B. E., Buitelaar, J. K., Minderaa, R. B., & Hoekstra, P. J.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-10
- Volume
- 16
- Issue
- 5
- Pages
- 561-573
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2086495048
- Cited by
- 33
- References
- 7
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study. https://app.cochat.ai/papers/10.1089/cap.2006.16.561
- The paper
- Troost, P. W., Althaus, M., Lahuis, B. E., Buitelaar, J. K., Minderaa, R. B., & Hoekstra, P. J. (2006). Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: ABlinded Discontinuation Study. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2006.16.561
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.